The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up

Wed, 20th May 2020 13:56

(Sharecast News) - Great Portland Estates: Peel Hunt downgrades to reduce with a target price of 630p.



RDI REIT: Berenberg upgrades to buy with a target price of 80p.

Centamin: Berenberg reiterates buy with a target price of 184p.

BT Group: Deutsche Bank reiterates hold with a target price of 125p.

Boohoo: Liberum reiterates buy with a target price of 430p.

Compass Group: Liberum reiterates hold with a target price of 1,200p.

Compass Group: Deutsche Bank upgrades to buy with a target price of 1,420p.

Frontier Developments: Peel Hunt reiterates buy with a target price of 2,073p.

Homeserve: JP Morgan reiterates overweight with a target price of 1,400p.

DCC: JP Morgan reiterates overweight with a target price of 8,963p.

Imperial Brands: Citigroup reiterates buy.
More News
15 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 14:59

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
13 Jul 2015 15:07

AGM, EGM Calendar - Week Ahead

Read more
13 Jul 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 16:11

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
9 Jul 2015 15:21

AGM, EGM Calendar - Week Ahead

Read more
9 Jul 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more
8 Jul 2015 15:20

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 14:51

Investec affirms 'buy' rating for BTG, confident about varicose vein treatment

Investec reiterated a 'buy' rating and price target of 647p for pharmaceuticals firm BTG after reappraising its key product Varithena. The bank said investors overreacted to concerns over BTG's earning profile, in particular the varicose vein treatment Varithena. "After interviewing physicians and

Read more
11 Jun 2015 10:26

WINNERS & LOSERS: RBS Rises, Royal Mail Sinks On UK Government Moves

Read more
11 Jun 2015 08:35

BROKER RATINGS SUMMARY: Liberum Raises Majestic Wine To Buy From Hold

Read more
11 Jun 2015 06:39

BTG Says First Patient Treated With TheraSphere In Singapore

Read more
27 May 2015 08:34

BROKER RATINGS SUMMARY: Brewin Dolphin Cut To Hold By Peel Hunt, Numis

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.